Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses
Standard
Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses. / Hartmann, Jordan A; Cardoso, Marcella R; Talarico, Maria Cecilia Ramiro; Kenney, Devin J; Leone, Madison R; Reese, Dagny C; Turcinovic, Jacquelyn; O'Connell, Aoife K; Gertje, Hans P; Marino, Caitlin; Ojeda, Pedro E; De Paula, Erich V; Orsi, Fernanda A; Velloso, Licio Augusto; Cafiero, Thomas R; Connor, John H; Ploss, Alexander; Hoelzemer, Angelique; Carrington, Mary; Barczak, Amy K; Crossland, Nicholas A; Douam, Florian; Boucau, Julie; Garcia-Beltran, Wilfredo F.
in: CELL, Jahrgang 187, Nr. 10, 09.05.2024, S. 2393-2410.e14.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses
AU - Hartmann, Jordan A
AU - Cardoso, Marcella R
AU - Talarico, Maria Cecilia Ramiro
AU - Kenney, Devin J
AU - Leone, Madison R
AU - Reese, Dagny C
AU - Turcinovic, Jacquelyn
AU - O'Connell, Aoife K
AU - Gertje, Hans P
AU - Marino, Caitlin
AU - Ojeda, Pedro E
AU - De Paula, Erich V
AU - Orsi, Fernanda A
AU - Velloso, Licio Augusto
AU - Cafiero, Thomas R
AU - Connor, John H
AU - Ploss, Alexander
AU - Hoelzemer, Angelique
AU - Carrington, Mary
AU - Barczak, Amy K
AU - Crossland, Nicholas A
AU - Douam, Florian
AU - Boucau, Julie
AU - Garcia-Beltran, Wilfredo F
N1 - Copyright © 2024 Elsevier Inc. All rights reserved.
PY - 2024/5/9
Y1 - 2024/5/9
N2 - SARS-CoV-2 and other sarbecoviruses continue to threaten humanity, highlighting the need to characterize common mechanisms of viral immune evasion for pandemic preparedness. Cytotoxic lymphocytes are vital for antiviral immunity and express NKG2D, an activating receptor conserved among mammals that recognizes infection-induced stress ligands (e.g., MIC-A/B). We found that SARS-CoV-2 evades NKG2D recognition by surface downregulation of MIC-A/B via shedding, observed in human lung tissue and COVID-19 patient serum. Systematic testing of SARS-CoV-2 proteins revealed that ORF6, an accessory protein uniquely conserved among sarbecoviruses, was responsible for MIC-A/B downregulation via shedding. Further investigation demonstrated that natural killer (NK) cells efficiently killed SARS-CoV-2-infected cells and limited viral spread. However, inhibition of MIC-A/B shedding with a monoclonal antibody, 7C6, further enhanced NK-cell activity toward SARS-CoV-2-infected cells. Our findings unveil a strategy employed by SARS-CoV-2 to evade cytotoxic immunity, identify the culprit immunevasin shared among sarbecoviruses, and suggest a potential novel antiviral immunotherapy.
AB - SARS-CoV-2 and other sarbecoviruses continue to threaten humanity, highlighting the need to characterize common mechanisms of viral immune evasion for pandemic preparedness. Cytotoxic lymphocytes are vital for antiviral immunity and express NKG2D, an activating receptor conserved among mammals that recognizes infection-induced stress ligands (e.g., MIC-A/B). We found that SARS-CoV-2 evades NKG2D recognition by surface downregulation of MIC-A/B via shedding, observed in human lung tissue and COVID-19 patient serum. Systematic testing of SARS-CoV-2 proteins revealed that ORF6, an accessory protein uniquely conserved among sarbecoviruses, was responsible for MIC-A/B downregulation via shedding. Further investigation demonstrated that natural killer (NK) cells efficiently killed SARS-CoV-2-infected cells and limited viral spread. However, inhibition of MIC-A/B shedding with a monoclonal antibody, 7C6, further enhanced NK-cell activity toward SARS-CoV-2-infected cells. Our findings unveil a strategy employed by SARS-CoV-2 to evade cytotoxic immunity, identify the culprit immunevasin shared among sarbecoviruses, and suggest a potential novel antiviral immunotherapy.
KW - Humans
KW - SARS-CoV-2/immunology
KW - Killer Cells, Natural/immunology
KW - NK Cell Lectin-Like Receptor Subfamily K/metabolism
KW - COVID-19/immunology
KW - Immune Evasion
KW - Histocompatibility Antigens Class I/immunology
KW - Animals
KW - Cytotoxicity, Immunologic
KW - Down-Regulation
KW - Lung/immunology
U2 - 10.1016/j.cell.2024.03.026
DO - 10.1016/j.cell.2024.03.026
M3 - SCORING: Journal article
C2 - 38653235
VL - 187
SP - 2393-2410.e14
JO - CELL
JF - CELL
SN - 0092-8674
IS - 10
ER -